Literature DB >> 19202965

Osteoporosis screening: mixed messages in primary care.

Margaret Gourlay.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19202965      PMCID： PMC3751589     

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN： 0002-838X            Impact factor:   3.292


× No keyword cloud information.
  12 in total

1.  Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Vincenza Snow; Paul Shekelle; Robert Hopkins; Mary Ann Forciea; Douglas K Owens
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

2.  Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference.

Authors:  Sanford Baim; Neil Binkley; John P Bilezikian; David L Kendler; Didier B Hans; E Michael Lewiecki; Stuart Silverman
Journal:  J Clin Densitom       Date:  2008 Jan-Mar       Impact factor: 2.617

3.  The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective.

Authors:  F Borgström; A Carlsson; H Sintonen; S Boonen; P Haentjens; R Burge; O Johnell; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2006-03-29       Impact factor: 4.507

4.  Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis.

Authors:  Ann Cranney; Gordon Guyatt; Lauren Griffith; George Wells; Peter Tugwell; Clifford Rosen
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

5.  Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Mark Helfand; Benjamin K S Chan; Steven H Woolf
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

Review 6.  Diagnosis and treatment of osteoporosis.

Authors:  Mary Gayle Sweet; Jon M Sweet; Michael P Jeremiah; Sim S Galazka
Journal:  Am Fam Physician       Date:  2009-02-01       Impact factor: 3.292

7.  Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.

Authors:  John T Schousboe; Brent C Taylor; Howard A Fink; Robert L Kane; Steven R Cummings; Eric S Orwoll; L Joseph Melton; Douglas C Bauer; Kristine E Ensrud
Journal:  JAMA       Date:  2007-08-08       Impact factor: 56.272

8.  Longitudinal trends in use of bone mass measurement among older americans, 1999-2005.

Authors:  Jeffrey R Curtis; Laura Carbone; Hong Cheng; Burton Hayes; Andrew Laster; Robert Matthews; Kenneth G Saag; Robert Sepanski; Simpson B Tanner; Elizabeth Delzell
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

Review 9.  The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

Authors:  J A Kanis; A Oden; O Johnell; H Johansson; C De Laet; J Brown; P Burckhardt; C Cooper; C Christiansen; S Cummings; J A Eisman; S Fujiwara; C Glüer; D Goltzman; D Hans; M-A Krieg; A La Croix; E McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; K Sanders; A-M Schott; A Silman; D Torgerson; T van Staa; N B Watts; N Yoshimura
Journal:  Osteoporos Int       Date:  2007-02-24       Impact factor: 4.507

10.  The cost-effectiveness of alendronate in the management of osteoporosis.

Authors:  John A Kanis; Judith Adams; Fred Borgström; Cyrus Cooper; Bengt Jönsson; Danielle Preedy; Peter Selby; Juliet Compston
Journal:  Bone       Date:  2007-11-12       Impact factor: 4.398
View more
  1 in total

1.  Screening for osteoporosis: A systematic assessment of the quality and content of clinical practice guidelines, using the AGREE II instrument and the IOM Standards for Trustworthy Guidelines.

Authors:  Lamia M Hayawi; Ian D Graham; Peter Tugwell; Said Yousef Abdelrazeq
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.